MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC)

This publication has 34 references indexed in Scilit:

• Analysis of human telomerase reverse transcriptase mRNA (hTERT) expression in myxoid liposarcomas using LightCycler real-time quantitative reverse transcriptase-polymerase chain reaction
  Electrophoresis, 2001
• Mdm2 Gene Amplification in Gastric Cancer Correlation with Expression of Mdm2 Protein and p53 Alterations
  Laboratory Investigation, 2000
• Global cancer statistics
  CA: A Cancer Journal for Clinicians, 1999
• TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis
  Oncogene, 1997
• Amplification of themdm-2 gene andp53 abnormalities in uterine sarcomas
  International Journal of Cancer, 1997
• Molecular pathology of primary and metastatic ductal pancreatic lesions
  Cancer, 1997
• A MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF THE MDM2 PROTEIN ISOFORMS ANDp53 GENE PRODUCT IN BRONCHOGENIC CARCINOMA
  The Journal of Pathology, 1996
• Infrequent mutations of theTP53 gene and no amplification of theMDM2 gene in hepatoblastomas
  Genes, Chromosomes and Cancer, 1996
• MDM2 gene amplification in human breast cancer
  European Journal Of Cancer, 1994
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
  Cell, 1992